Hypogammaglobulinemia secondary to B-cell depleting therapies in neuroimmunology: Comparing management strategies.

Hannah KellyAnastasia VishnevetskyLori B ChibnikMichael Levy

Published in: Multiple sclerosis journal - experimental, translational and clinical (2023)

This data suggests that IVIG/SCIG may yield the greatest recovery in IgG while also reducing infection frequency and severity. Stopping anti-CD20 therapy and/or switching DMTs also increase IgG and may lower infection risk.

Keyphrases

big data
machine learning
stem cells
mesenchymal stem cells
bone marrow
artificial intelligence
smoking cessation